Clinical Trials Browser

Phase 4 × Interventional × drotrecogin alfa activated × Clear all

NCT00067730 2007-12-07

A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation

Phase 4 Completed

Other hematologic neoplasm

Infections, Sepsis, Hematologic Neoplasms